Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
University of Kansas
Search grants from University of Kansas
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PS10-1092, Botswana: Implementing the Living Life Skills Curriculum in Botswana
Transcriptional output pathways of the circadian clock
Mosquito Immunity Functions
Low-Dimensional Chaos in Neocortex
Deleterious Microalgal Toxins
Recently added grants:
Histamine Regulation of the Basal Ganglia and the Pathophysiology of Tics
Interactions Between Host Genetics and the Gut Microbiome in CNS Autoimmunity
Redox Signaling in Neurofibromatosis
A vasculo-protective role for beta4 integrin in neuroinflammation
Signaling pathways that regulate scaling and regeneration of the cerebellum
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075035-003
Application #
6688591
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Kansas
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
NIH 2002
N01 CA
Phase I Single and Multiple Dose Safety, Pharmacokinetic-261975035
/ University of Kansas
Comments
Be the first to comment on this grant